À
Organocatalytic Asymmetric a-Sulfenylation of Activated C H Bonds
FULL PAPER
General procedure for the organocatalytic a-sulfenylation of b-keto
esters: The catalyst (0.05 mmol) was dried in a Schlenk tube by evacuat-
ing for 15 min. Toluene (5 mL) was added under an N2 atmosphere. Then
the b-keto ester (0.5 mmol) was added to the solution at appropriate tem-
perature (Table 3), followed by the addition of the electrophilic sulfur re-
agent (0.6 mmol). The reaction mixture was stirred for the appropriate
time (Table 3) and then quenched with 1m aqueous KHSO4 (3 mL).
After standard aqueous workup, the product was purified by flash chro-
matography.
HRMS: m/z calcd for C18H15ClO3S: 369.0328; found: 369.0318 [M+Na]+;
[a]D =+33.8 (c=10 mgmLÀ1, 51% ee).
Benzyl 2-benzylsulfanyl-1-oxoindan-2-carboxylate (3e): The enantiomeric
excess was determined by HPLC using a Daicel Chiralpack AD column
(hexane/iPrOH) (90:10); flow rate 1.0 mLminÀ1; tmajor =14.9; tminor =16.1;
1H NMR: d=3.02 (d, J=18 Hz, 1H; CH2), 3.78 (d, J=18 Hz, 1H; CH2),
3.98 (d, J=12 Hz, 1H; CH2C6H5), 4.07 (d, J=12 Hz, 1H; CH2C6H5), 5,10
(d, J=12.4 Hz, 1H; CH2C6H5), 5.16 (d, J=12.4 Hz, 1H; CH2C6H5), 7.08–
7.40 (m, 12H; ArH), 7.50–7.54 (m, 1H; ArH), 7.77 ppm (d, J=7.6 Hz,
1H; ArH); 13C NMR: d=35.3, 40.2, 59.3, 68.3, 126.0, 126.6, 127.7–129.9,
135.9, 150.7, 169.6, 196.8 ppm; HRMS: m/z calcd for C24H20O3S:
Ethyl 1-benzylsulfanyl-2-oxocyclopentanecarboxylate (3a): The enantio-
meric excess was determined by HPLC using a Daicel Chiralpack AD
411.1031; found: 411.1096 [M+Na]+; [a]D =+15.2 (c=10 mgmLÀ1
60% ee).
,
column (hexane/iPrOH) (90:10); flow rate 1.0 mLminÀ1
; tmajor =6.0;
tminor =6.5; 1H NMR: d=1.22 (t, J=6.8 Hz, 3H; CH2CH3), 1.88–2.12 (m,
3H; CH2), 2.27–2.39 (m, 1H; CH2), 2.48–2.61 (m, 2H; CH2), 3.70 (d, J=
12 Hz, 1H; CH2C6H5), 4.00 (d, J=12 Hz, 1H; CH2C6H5), 4.14 (q, J=
6.8 Hz, 2H; CH2CH3), 7.15–7.23 ppm (m, 5H; ArH); 13C NMR: d=14.5,
19.6, 35.2, 35.7, 36.7, 62.5, 69.3, 127.6, 129.1, 129.7, 131.7, 169.7,
206.8 ppm; HRMS: m/z calcd for C15H18O3S: 301.0874; found: 301.0862
[M+Na]+; [a]D =À76.9 (c=10 mgmLÀ1, 63% ee).
Methyl 1-benzylsulfanyl-2-oxoindan-1-carboxylate (3 f): The enantiomeric
excess was determined by HPLC using a Daicel Chiralpack AS column
(hexane/iPrOH) (99:1); flow rate 1.0 mLminÀ1; tmajor =14.7; tminor =11.3;
1H NMR: d=3.68 (s, 3H; CH3), 3.71 (d, J=8.8 Hz, 2H; CH2), 3.89 (d,
J=12 Hz, 1H; CH2C6H5), 3.99 (d, J=12 Hz, 1H; CH2C6H5), 7.20–7.38
(m, 8H; ArH), 7.44–7.46 ppm (m, 1H; ArH); 13C NMR: d=35.9, 42.0,
53.8, 64.6, 125.6, 127.6–130.0, 136.4, 138.2, 168.3, 205.7 ppm; HRMS: m/z
calcd for C18H16O3S: 335.0718; found: 335.0709 [M+Na]+; [a]D =+18.7
(c=10 mgmLÀ1, 53% ee).
Isopropyl 1-benzylsulfanyl-2-oxocyclopentanecarboxylate (3b): The enan-
tiomeric excess was determined by HPLC using a Daicel Chiralpack AD
column (hexane/iPrOH) (98:2); flow rate 1.0 mLminÀ1
; tmajor =7.3;
1
Ethyl 3-benzylsulfanyl-2-oxo-1-(toluene-4-sulfonyl)pyrolidine-3-carboxyl-
ate (3g): The enantiomeric excess was determined by HPLC using a
Daicel Chiralpack AS column (hexane/iPrOH) (95:5); flow rate
1.0 mLminÀ1; tmajor =33.8; tminor =30.1; 1H NMR: d=1.15 (t, J=7.2 Hz,
3H; CH2CH3),1.89–1.95 (m, 1H; CH2), 2.38 (s, 3H; CH3), 2.62–2.70 (m,
1H; CH2), 3.38 (d, J=11.2 Hz, 1H; CH2C6H5), 3.71–3.77 (m, 1H; CH2),
3.86 (d, J=11.2 Hz, 1H; CH2C6H5), 3.90–3.92 (m, 1H; CH2), 4.10 (q, J=
7.2 Hz, 2H; CH2CH3) 6.91–6.93 (m, 2H; ArH), 7.13–7.18 (m, 3H; ArH),
7.29 (d, J=8.4 Hz, 2H; ArH), 7.88 ppm (d, J=8.4 Hz, 2H; ArH);
13C NMR: d=14.4, 22.1, 30.5, 35.3, 44.6, 57.6, 63.2, 127.8, 129.0, 129.6,
130.1, 134.3, 135.7, 146.0, 166.9, 167.8 ppm; HRMS: m/z calcd for
C21H23NO5S2: 456.0915; found: 456.0920 [M+Na]+; [a]D =À14.4 (c=
10 mgmLÀ1, 59% ee).
tminor =8.3; H NMR: d=1.28 (d, J=5.6 Hz, 6H; CH3), 1.93–2.17 (m, 3H;
CH2), 2.32–2.43 (m, 1H; CH2), 2.53–2.67 (m, 2H; CH2), 3.79 (d, J=
11.6 Hz, 1H; CH2C6H5), 4.07 (d, J=11.6 Hz, 1H; CH2C6H5), 5.08 (hep,
J=6.4 Hz, 1H; CHCH3), 7.19–7.33 ppm (m, 5H; ArH); 13C NMR: d=
19.7, 22.1, 35.2, 35.4, 36.8, 60.9, 70.4, 127.7, 129.0, 129.8, 136.9, 169.4,
207.0 ppm; HRMS: m/z calcd for C16H20O3S: 315.1031; found: 315.1024
[M+Na]+; [a]D =À102.9 (c=10 mgmLÀ1, 71% ee).
tert-Butyl 1-benzylsulfanyl-2-oxocyclopentanecarboxylate (3c): The enan-
tiomeric excess was determined by HPLC using a Daicel Chiralpack AD
column (hexane/iPrOH) (98:2); flow rate 1.0 mLminÀ1
; tmajor =6.3;
tminor =7.5; 1H NMR: d=1.42 (s, 9H; C4H9), 1.84–2.07 (m, 3H; CH2),
2.13–2.34 (m, 1H; CH2), 2.43–2.57 (m, 2H; CH2), 3.73 (d, J=11.6 Hz,
1H; CH2C6H5), 4.00 (d, J=11.6 Hz, 1H; CH2C6H5), 7.13–7.28 ppm (m,
5H; ArH); 13C NMR: d=19.7, 28.3, 35.2, 35.9, 36.9, 61.4, 83.3, 127.7,
129.8, 129.8, 136.9, 168.8, 207.4 ppm; HRMS: m/z calcd for C17H22O3S:
tert-Butyl
boxylate (3h): The enantiomeric excess was determined by HPLC using
Daicel Chiralcel OD column (hexane/iPrOH) (98:2); flow rate
3-benzylsulanyl-2-oxo-1-(toluene-4-sulfonyl)pyrolidine-3-car-
a
329.1187; found: 329.1179 [M+Na]+; [a]D =À106.0 (c=10 mgmLÀ1
89% ee).
,
1.0 mLminÀ1; tmajor =22.5; tminor =20.3; 1H NMR: d=1.37 (s, 9H; C4H9),
1.85–1.91 (m, 1H; CH2), 2.38 (s, 3H; CH3), 2.60–2.68 (m, 1H; CH2), 3.37
(d, J=11.2 Hz, 1H; CH2C6H5), 3.69–3.75 (m, 1H; CH2), 3.87 (d, J=
12 Hz, 1H; CH2C6H5), 3.91–3.94 (m, 1H; CH2), 6.90–6.95 (m, 2H; ArH),
7.10–7.28 (m, 5H; ArH), 7.87–7.89 ppm (m, 2H; ArH); 13C NMR: d=
22.1, 28.2, 30.6, 35.3, 44.7, 58.5, 84.4, 127.8, 128.8, 130.0, 134.5, 135.9,
145.9, 166.6, 167.2 ppm; HRMS: m/z calcd for C21H23NO5S2: 484.1228;
found: 484.1294 [M+Na]+; [a]D =À42.8 (c=5 mgmLÀ1, 85% ee).
tert-Butyl 1-isopropylsulfanyl-2-oxocyclopentanecarboxylate (5): The en-
antiomeric excess was determined by HPLC using a Daicel Chiralpack
AD column (hexane/iPrOH) (98:2); flow rate 1.0 mLminÀ1; tmajor =4.3;
tminor =4.7; 1H NMR: d=1.12 (d, J=6.4 Hz, 3H; CH3), 1.25 (d, J=
6.4 Hz, 3H; CH3), 1.40 (s, 9H; C4H9), 1.83–1.96 (m, 2H; CH2), 1.99–2.11
(m, 1H; CH2), 2.20–2.29 (m, 1H; CH2), 2.39–2.52 (m, 2H; CH2),
3.15 ppm (hep, J=6.8 Hz, 1H; CHCH3); 13C NMR: d=19.3, 25.1, 28.2,
35.5, 36.3, 36.9, 60.9, 82.8, 169.5, 207.7 ppm; HRMS: m/z calcd for
C13H22O3S: 281.1187; found: 281.1194 [M+Na]+; [a]D =À83.2 (c=
10 mgmLÀ1, 79% ee).
2-Benzylsulfanyl-2-(3,3-dimethyl-butyryl)cyclopentanone (3i): The enan-
tiomeric excess was determined by HPLC using a Daicel Chiralpack AD
column (hexane/iPrOH) (90:10); flow rate 1.0 mLminÀ1
; tmajor =4.8;
tminor =5.4; 1H NMR: d=0.92 (s, 9H; C4H9), 1.76–2.04 (m, 3H; CH2),
2.22–2.34 (m, 2H; CH2), 2.40–2.56 (m, 3H; CH2), 3.59 (d, J=12 Hz, 1H;
CH2C6H5), 3.66 (d, J=12, 1H; CH2C6H5), 7.14–7.25 ppm (m, 5H; ArH);
13C NMR: d=19.4, 29.8, 30.3, 34.0, 38.1, 50.1, 67.5, 127.7, 128.9, 129.5,
136.6, 198.7, 209.4 ppm; HRMS: m/z calcd for C18H24O2S: 327.1395;
found: 327.1393 [M+Na]+; [a]D =À33.7 (c=10 mgmLÀ1, 70% ee).
tert-Butyl
(6): The enantiomeric excess was determined by HPLC using a Daicel
Chiralpack AD column (hexane/iPrOH) (90:10); flow rate 1.0 mLminÀ1
1-(2,4-dinitrophenylsulfanyl)-2-oxocyclopentanecarboxylate
;
tmajor =10.0; tminor =12.8; 1H NMR: d=1.36 (s, 9H; C4H9), 2.04–2.12 (m,
2H; CH2), 2.28–2.35 (m, 1H; CH2), 2,41–2,50 (m, 1H; CH2), 2.51–2.67
(m, 2H; CH2), 8.05 (d, J=9.2 Hz, 1H; ArH), 8.24 (d, J=9.2 Hz, 1H;
ArH), 8.90 ppm (s, 1H; ArH); 13C NMR: d=19.9, 28.2, 37.6, 37.7, 64.4,
85.1, 121.5, 126.8, 131.9, 142.8, 145.5, 167.8, 208.0 ppm; HRMS: m/z calcd
for C16H18N2O7S: 405.0732 found: 405.0740 [M+Na]+; [a]D =+363 (c=
5 mgmLÀ1, 83% ee).
General procedure for the diastereoselective reduction of optically active
a-sulfanyl b-keto esters: To
a solution of a-sulfanyl b-keto ester
(0.5 mmol) in THF (5 mL) was added one equivalent of BH3·DMS. After
the reaction mixture had been stirred at room temperature for 1–2 days,
the reaction was quenched with H2O (5 mL) and the mixture was extract-
ed with Et2O (35 mL). The organic layer was then dried over anhy-
drous Na2SO4, filtered, and evaporated. The crude reaction mixture was
purified by flash chromatography to give the optically active a-sulfanyl
b-hydroxy esters.
Methyl 2-benzylsulfanyl-5-chloro-1-oxoindan-2-carboxylate (3d): The en-
antiomeric excess was determined by HPLC using a Daicel Chiralpack
AD column (hexane/iPrOH) (90:10); flow rate 1.0 mLminÀ1; tmajor =11.4;
tminor =12.2; 1H NMR: d=2.99 (d, J=18 Hz, 1H; CH2), 3.63 (s, 3H;
CH3), 3.74 (d, J=18 Hz, 1H; CH2), 3.95 (d, J=12 Hz, 1H; CH2C6H5),
4.09 (d, J=12 Hz, 1H; CH2C6H5), 7.11–7.23 (m, 6H; ArH), 7.29 (d, J=
7.6 Hz, 1H; ArH), 7.66 ppm (d, J=8.8 Hz, 1H; ArH); 13C NMR: d=
35.3, 39.9, 53.8, 59.3, 126.5–129.7, 136.5, 142.4, 152.2, 169.7, 195.4 ppm;
tert-Butyl
1-benzylsulfanyl-2-hydroxycyclopentanecarboxylate
(7):
1H NMR: d=1.45 (s, 9H; C4H9), 1.50–1.55 (m, 1H; CH2), 1.70–1.84 (m,
4H; CH2), 2.15–2.22 (m, 1H; CH2), 3.70 (d, J=12.4 Hz, 1H; CH2C6H5),
3.79 (d, J=12.4 Hz, 1H; CH2C6H5), 4.25 (t, J=4 Hz, 1H; CH), 7.16–
Chem. Eur. J. 2005, 11, 5689 – 5694
ꢀ 2005 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
5693